OS Therapies OSTX
NYSE OSTX
$1.27 +0.00 (+0.00%)
As of: Oct 22, 2026 · 11:39 AM EDT

OS Therapies (OSTX) Other non-cash items (2025)

Updated

Analysis

OS Therapies (OSTX) Other non-cash items (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn
10 OS Therapies 6.06 Mn 2.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -302,042.00
Mar 31, 2025 -1.12 Mn
API Access

OS Therapies Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=OSTX&period=max&api_key=YOUR_API_KEY